| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | CONCERT PHARMACEUTICALS, INC. | 3,202,774 | 6.5% | EDGAR |
| SC 13G/A | 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. | CONCERT PHARMACEUTICALS, INC. | 5,199,746 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-14 | PERCEPTIVE ADVISORS LLC | CONCERT PHARMACEUTICALS, INC. | 1,800,000 | 3.6% | EDGAR |
| SC 13G | 2023-02-10 | Kynam Capital Management, LP | CONCERT PHARMACEUTICALS, INC. | 4,420,349 | 9.2% | EDGAR |
| SC 13G | 2023-02-10 | Kynam Capital Management, LP | CONCERT PHARMACEUTICALS, INC. | 4,420,349 | 9.2% | EDGAR |
| SC 13G/A | 2022-02-14 | RA CAPITAL MANAGEMENT, L.P. | CONCERT PHARMACEUTICALS, INC. | 3,510,103 | 10.0% | EDGAR |
| SC 13G/A | 2022-02-14 | PERCEPTIVE ADVISORS LLC | CONCERT PHARMACEUTICALS, INC. | 2,150,641 | 6.2% | EDGAR |
| SC 13G/A | 2022-01-13 | BANK OF AMERICA CORP /DE/ | CONCERT PHARMACEUTICALS, INC. | 1,007,258 | 2.9% | EDGAR |
| SC 13G | 2021-11-15 | BIOTECHNOLOGY VALUE FUND L P | CONCERT PHARMACEUTICALS, INC. | 2,565,757 | 7.1% | EDGAR |
| SC 13G/A | 2021-07-12 | BlackRock Inc. | CONCERT PHARMACEUTICALS, INC. | 670,035 | 2.1% | EDGAR |
| SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | CONCERT PHARMACEUTICALS, INC. | 2,150,641 | 7.0% | EDGAR |
| SC 13G | 2021-02-16 | RA CAPITAL MANAGEMENT, L.P. | CONCERT PHARMACEUTICALS, INC. | 1,823,520 | 5.9% | EDGAR |
| SC 13G/A | 2021-02-12 | DIMENSIONAL FUND ADVISORS LP | CONCERT PHARMACEUTICALS, INC. | 1,079,170 | 3.5% | EDGAR |
| SC 13G/A | 2021-02-09 | INGALLS & SNYDER LLC | CONCERT PHARMACEUTICALS, INC. | 1,396,003 | 4.6% | EDGAR |
| SC 13G/A | 2021-02-08 | BANK OF AMERICA CORP /DE/ | CONCERT PHARMACEUTICALS, INC. | 1,878,218 | 6.1% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | CONCERT PHARMACEUTICALS, INC. | 2,204,509 | 7.2% | EDGAR |
| SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | CONCERT PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | PERCEPTIVE ADVISORS LLC | CONCERT PHARMACEUTICALS, INC. | 2,150,641 | 9.0% | EDGAR |
| SC 13G/A | 2020-02-14 | GLAXOSMITHKLINE PLC | CONCERT PHARMACEUTICALS, INC. | 1,179,941 | 4.1% | EDGAR |
| SC 13G/A | 2020-02-14 | RTW INVESTMENTS, LP | CONCERT PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |